Peptide digest and MS: 50 µg of holo-TamA was denatured by addition of 8 M urea to a final concentration of 6 M before incubation at room temperature for 2 hours. The protein was subsequently reduced with DTT added to a final concentration of 5 mM and further incubated at room temperature for 30 mins. The samples were alkylated with iodoacetamide at a final concentration of 10 mM at room temperature in the dark for 30 mins. This reaction was quenched by adding more DTT to a final concentration of 10 mM and incubating at room temperature for 30 mins. The sample was then diluted to a urea concentration of less than 1 M with 50 mM ammonium bicarbonate. Finally, 1 µg of trypsin was added to the sample and this was incubated at 37 °C overnight. The samples were cleaned using C18 100 µL ziptips and washed in 0.2 % formic acid. Peptides were eluted in 60 % ACN with 0.2 % formic acid. The resulting peptide mixtures were analysed using a Bruker solariX XR 12T. The solariX was operated in positive ion mode and protein was infused using nano-ESI on a TriVersa nanomate (Advion). Data was acquired over an m/z range of 200 -5000 with an average of 30-50 scans per sample and an accumulation time of 0.2 seconds. Spectra were processed and calibrated with DataAnalysis version 4.2. The [M+3H] 3+ ion containing 4'-PP modification was isolated for further MS/MS analysis. In order to isolate this ion, the accumulation time was increased to 2 seconds and an average of 50 spectra were acquired with a 2 Da window. The resulting product ion spectrum of [M+3H] 3+ was then analysed for y and b ions corresponding to a 4'-PP modification using prositeLite.
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TamCluster 25750 bp TamA  TamC  TamB  TamE  TamF TamG  TamH  TamI  TamJ  TamM  TamO TamP  TamQ  TamR  TamS TamT  TamD  TamN  TamK   TamB  TamC   TamD  TamE TamF TamG  TamJ  TamH   TamK  TamA  TamN   TamO  TamP   TamM  TamI  TamR TamQ TamS TamT Figure S1 : Organisation of the 19 open reading frames (ORFs) of the tambjamine YP1 gene cluster 2 . Table S1 gives the Genbank code and predicted function for each gene.
[5] [6] Figure S4: The UNIPROT code A4C5W5 was used to design expression of TamA. Small changes were made (addition of GA at the beginning of the sequence and E2Q) during cloning. Amino acid sequence of TamA with the predicted (BLASTP) 3 adenylation (ANL) domain in blue and the acyl carrier protein (ACP) domain in purple with short connecting "linker" sequence in between (GEQIAPREVS) . In bold, underlined are the two DSV motifs which could be the attachment sites for 4'-phosphopantetheine (4'-PP). The serine in red (S622) is predicted to be the modification site. TamA after nickel affinity purification, Lane 2: flow-through of second nickel affinity purification after TEV cleavage of the 6xHis-tag, Lane 3: elution from nickel affinity after TEV cleavage, Lanes 4-9: fractions from the Superdex HR S200 (GE Healthcare) gel filtration chromatography (3 mL fractions from 67-85 mL), (b) chromatogram of TamA isolation by gel filtration chromatography.
[9] [16]
Figure S13: Alignment of the TamA amino acid sequence with sequences from parts of four NRPS proteins. The NRPSs contain peptide carrier protein (PCP) domains. Six crystal structures of these four proteins EntF (PDB codes: 5T3D, 5JA2), AB3403 (4ZXI), LgrA (5ES8) and SrfA-C (5U89, 2VSQ) were used in the production of the TamA structure model. Highlighted are the conserved ATP binding P-loop (yellow), the FAAL insertion loop (orange), the hinge region (pink) and the predicted carrier domain (CP, purple) with its conserved serine residue S622 (red, this is missing in SrfA-C since the 4'-PP site of the PCP has been mutated). Figure 5 after reaction with TamA, fatty acid, Mg 2+ and ATP. The table shows the observed and predicted masses of the proteins, as well as the observed and predicted mass changes expected for the addition of the acyl chain.
